Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 4 | 2015 | 87 | 0.570 |
Why?
|
| X-linked Nuclear Protein | 1 | 2017 | 2 | 0.560 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2017 | 3 | 0.560 |
Why?
|
| Cysts | 1 | 2017 | 12 | 0.550 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 11 | 0.550 |
Why?
|
| Calcinosis | 1 | 2017 | 44 | 0.540 |
Why?
|
| Ependymoma | 2 | 2013 | 17 | 0.510 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2013 | 4 | 0.410 |
Why?
|
| Glioma, Subependymal | 1 | 2013 | 5 | 0.410 |
Why?
|
| Granular Cell Tumor | 1 | 2011 | 3 | 0.350 |
Why?
|
| Astrocytoma | 1 | 2011 | 15 | 0.350 |
Why?
|
| Ascitic Fluid | 1 | 2010 | 9 | 0.340 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2010 | 16 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2017 | 1044 | 0.250 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 340 | 0.200 |
Why?
|
| Humans | 12 | 2017 | 25950 | 0.170 |
Why?
|
| Mutation | 2 | 2017 | 334 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 39 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 644 | 0.130 |
Why?
|
| Female | 6 | 2017 | 14422 | 0.130 |
Why?
|
| Adult | 4 | 2017 | 7658 | 0.120 |
Why?
|
| Malformations of Cortical Development | 1 | 2015 | 2 | 0.120 |
Why?
|
| Ganglioglioma | 1 | 2015 | 6 | 0.120 |
Why?
|
| Central Nervous System Cysts | 1 | 2015 | 6 | 0.120 |
Why?
|
| Dermoid Cyst | 1 | 2015 | 5 | 0.120 |
Why?
|
| Neurosurgical Procedures | 2 | 2015 | 136 | 0.120 |
Why?
|
| Scalp | 1 | 2015 | 6 | 0.120 |
Why?
|
| Epilepsy | 1 | 2015 | 68 | 0.110 |
Why?
|
| Lymphoma | 1 | 2015 | 36 | 0.110 |
Why?
|
| Pineal Gland | 1 | 2014 | 4 | 0.110 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2013 | 4 | 0.110 |
Why?
|
| Coloring Agents | 1 | 2013 | 14 | 0.100 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 18 | 0.100 |
Why?
|
| Male | 5 | 2017 | 14087 | 0.100 |
Why?
|
| Histiocytosis, Sinus | 1 | 2011 | 4 | 0.090 |
Why?
|
| Middle Aged | 4 | 2017 | 8653 | 0.090 |
Why?
|
| Arthritis | 1 | 2011 | 52 | 0.090 |
Why?
|
| Humerus | 1 | 2011 | 105 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2010 | 17 | 0.090 |
Why?
|
| Xanthine Dehydrogenase | 1 | 2010 | 6 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2015 | 3422 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 124 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 240 | 0.070 |
Why?
|
| Shoulder Joint | 1 | 2011 | 657 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 546 | 0.060 |
Why?
|
| Aged | 3 | 2015 | 8480 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 360 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 4409 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 1984 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 1717 | 0.040 |
Why?
|
| Adolescent | 2 | 2013 | 2123 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 13 | 0.030 |
Why?
|
| Parakeratosis | 1 | 2015 | 1 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 2015 | 14 | 0.030 |
Why?
|
| Skull | 1 | 2015 | 19 | 0.030 |
Why?
|
| Cell Nucleus Shape | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 8 | 0.030 |
Why?
|
| 12E7 Antigen | 1 | 2013 | 3 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 12 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2013 | 31 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 22 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2015 | 414 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2013 | 40 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2013 | 51 | 0.030 |
Why?
|
| Carcinoma | 1 | 2013 | 68 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3469 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 506 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 554 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 205 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 193 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 258 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 592 | 0.020 |
Why?
|
| Smoking | 1 | 2010 | 172 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 366 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 3575 | 0.010 |
Why?
|